HAE

NEUTRALTechnicalPick of the Day

Haemonetics Corporation

Price
$106.82
-1.57%

Signal52 tracks Haemonetics Corporation across 25+ technical signals, monitoring regime shifts, volatility patterns, and institutional flow. Our AI analyzes HAE daily, identifying actionable setups and risk levels based on multi-timeframe confluence and market conditions.

Pick of the Day

Haemonetics (HAE) is perfectly positioned for a powerful trend continuation following its highly material Q1 FY27 financial results, which act as an immediate fundamental driver to resolve recent short-term consolidation. With the broader market in a definitive Risk-On regime characterized by compressing volatility and robust participation, this high-quality market leader is primed to resume its primary uptrend. The stock boasts an exceptional 8.0 technical confluence score, highlighted by a perfect moving average stack and a freshly triggered Bargain Hunter dip-buy signal.

Trading just 1.8% below its 52-week high on 1.1x average 20-day volume, HAE is demonstrating relative strength and absorbing recent consolidation (-1.4% over 20 days) with ease.

Horizon7 days vs S&P 500
View Full Pick Analysis →
Latest Analysis

HAE Stock Analysis - 2026-09-23

Haemonetics (HAE) is currently digesting a massive 48% 90-day run-up fueled by a renewed CSL Plasma supply deal and an enterprise-wide margin expansion narrative. Technical signals like STEADY_CLIMB and PERFECT_STACK confirm deep institutional accumulation, suggesting the recent 1.5% pullback is merely routine profit-taking near analyst fair-value targets rather than trend exhaustion. Supported by a robust RISK_ON macro regime and strong PMI data that is overpowering rate jitters, HAE's market leadership profile makes this consolidation a highly constructive setup for continuation.

Key Takeaways

  • Actionable Thesis: Accumulate shares during this minor consolidation phase, as the structural drivers of margin expansion and the CSL Plasma deal remain firmly intact.
  • Key Risk: A higher debt load and concentrated exposure to key product lines (NexSys, TEG) leave the stock vulnerable to execution stumbles or margin compression.
  • What to Watch: Price action around the $101.06 line-in-the-sand; holding this 20-day low confirms the bullish momentum is still absorbing supply.

Technical Signals

Score: 8
Priority
DNA Signals
STEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACK
Action Signals
BARGAIN HUNTER
Risk Signals
DISTRIBUTION
How to Interpret This Analysis
  • This analysis reflects market conditions on the stated date and is not predictive.
  • Signal52 identifies technical patterns and regime context, not forecasts or investment advice.
  • Historical signal performance does not guarantee future outcomes.
  • When citing or referencing Signal52, always include the analysis date for accuracy.
  • For the latest analysis, use dated URLs (/daily/YYYY-MM-DD) rather than assuming current conditions.
© 2026 Signal52 • For educational purposes only